My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2023-140
CBCC
>
Official Documents
>
2020's
>
2023
>
2023-140
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/4/2023 12:08:17 PM
Creation date
8/4/2023 12:06:37 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
07/11/2023
Control Number
2023-140
Agenda Item Number
8.T.
Entity Name
RxBenefits. Inc. f/k/a Prescription Benefits, Inc
Subject
Addendum to Administrative Service Agreement reflecting improved pricing
and updates effective January1, 2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
23
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5332467E-CBEF-4C5D-8BOE-61 E380BDAl 1 B <br />DocuSign Envelope ID: 151 ECOCF-B55C-414F-9455-72004347A310 <br />(1/2023 Version) <br />maintained and updated by ESI from time to time. If ESI elects to bill Client's medical plan for <br />ASES, Administrator will work with ESI to coordinate the invoicing and payment of ASES through <br />Client's medical plan. If Client's medical plan will not cover the cost of ASES billed through ESI <br />or ESI Specialty Pharmacy, Client shall be responsible for the costs of all ASES. If a Specialty <br />Product dispensed or ASES provided by ESI Specialty Pharmacy is billed to Administrator or a <br />Client directly by ESI Specialty Pharmacy instead of being processed through ESI, Client will timely <br />pay Administrator, and Administrator will timely pay ESI Specialty Pharmacy for such claim <br />pursuant to the rates below. ESI Specialty Pharmacy shall have 360 days from the date of service <br />to submit such electronic or paper claim. <br />Therapeutic Cla ss <br />Am <br />Immune Deficiency <br />MMENNOC11 Brand Name <br />All Immune Deficiency Drugs requiring <br />Nursing & Per Diem <br />$60.00 / Infusion <br />Per Diem <br />Enzyme Deficiency <br />All Enzyme Deficiency Drugs required <br />$60.00 / Infusion <br />Per Diem <br />Miscellaneous Specialty <br />Duopa <br />$65.00 / Day <br />Conditions <br />Miscellaneous Specialty <br />Soliris <br />$60.00 Infusion <br />Conditions <br />PAH <br />Flolan, Veletri, Epoprostenol Sodium <br />$65.00 / Day <br />(generic-Flolan/Veletri), and Remodulin <br />PAH <br />Ventavis <br />$65.00 / Day <br />PAH <br />Tyvaso <br />$30.00 / Day <br />Inflammatory Conditions <br />Remicade <br />560.00 / Infusion <br />Alpha I Deficiency <br />All Alpha I Deficiency Drugs requiring <br />$55.00/Infusion <br />Per Diem <br />Nursing Rates <br />All drugs / therapies requiring nursing <br />$150.00 per initial visit up to two <br />(2) hours/$75.00 per additional <br />hour or a fraction thereof <br />(g) Specialty Products will be excluded from the non -specialty price guarantees set forth in the <br />Agreement. In no event will the ESI Mail Pharmacy or Participating Pharmacy pricing terms <br />specified in the Agreement, including, but not limited to, the annual average ingredient cost discount <br />guarantees, apply to Specialty Products. <br />3.3 Vaccine Claims (NO VACCINE CLAIMS WILL BE INCLUDED IN ANY PRICING OR <br />REBATE GUARANTEE SET FORTH IN THE AGREEMENT). <br />(a) General terms applicable to Vaccine Claims <br />"Vaccine Claim" means a claim for a Covered Drug which is a vaccine. <br />"Vaccine Vendor Transaction Fee" means the data interchange fee that ESI is charged by <br />its third party vendor to convert Vaccine Claims submitted electronically by physicians to <br />NCPDP 5.1 format in order for PBM to process the claim. <br />Vaccine Claims shall adjudicate at the lower of U&C or the amounts shown in the table <br />below. In the case of Vaccine Claims, the U&C shall be the retail price charged by a <br />Participating Pharmacy for the particular vaccine, including administration and dispensing <br />15 <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.